Associate Professor Caroline Baker FRACS
Clinical Program Director, Surgical Services
Director of Breast Surgery St Vincent’s Hospital
Designated Surgeon St Vincent’s BreastScreen
President, BreastSurgANZ
Associate Professor Caroline Baker is Head of Breast Surgery at St Vincent’s Public Hospital Melbourne, after having serving for 6 years as Director of Breast Services at the Olivia Newton John Cancer and Wellness Centre. She is also Chief Surgeon to St Vincent’s Breast Screen . She gained her FRACS in 1994, then spent 5 years in The UK, subspecialising in the emerging field of breast surgery under the mentorship Mr. Mark Kissin and at The Royal Marsden Hospital in London.
Caroline is a foundation member of BreastSurgANZ, a longterm member of the Australasian Society of Breast Diseases and has been a member of BCT/ANZBCTG since 1998. Caroline regularly teaches students, junior doctors and registrars through The University of Melbourne, lymphoedema practitioners, nurses and volunteers within the Breast Cancer Network of Australia. She has a special interest in neoadjuvant therapy, lymphedema prevention and multidisciplinary care.

Mr Michael Boland completed his undergraduate training in University College Dublin in 2010 and completed Higher Surgical Training in Ireland in 2021. He undertook a competitively appointed TIG National Breast Oncoplastic Fellowship in Imperial College London in 2022, where he was subsequently appointed as a Consultant Oncoplastic Breast Surgeon. He commenced his post as a Consultant Oncoplastic Breast Surgeon in SVPH in Summer 2023.
Areas of interest include oncoplastic treatment of breast cancer with a specific focus on breast conserving surgery with mammoplasty, partial/whole breast reconstruction as well as a special interest in the management of axillary disease.

Judy C. Boughey, M.D., is a breast surgeon and professor of surgery at Mayo Clinic. She is the program director of the breast surgical oncology fellowship at Mayo Clinic and is the immediate past-president of the American Society of Breast Surgeons and sits on the ASBrS Board of Directors. She is chair of the American College of Surgeons Clinical Research Program and a member of the American Surgical Association. Dr. Boughey is recognized with the distinction of the W.H. Odell Professorship in Individualized Medicine.
Dr. Boughey has led multiple national clinical trials; ACOSOG Z1071 evaluating sentinel node surgery in node-positive breast cancer treated with neoadjuvant chemotherapy, ACOSOG Z11102 evaluating breast conservation in multiple ipsilateral breast tumors and ALLIANCE A11202 comparing axillary dissection to axillary radiation for node-positive disease after neoadjuvant chemotherapy. She is author of over 400 peer-reviewed papers.

Peter Chin is the lead breast surgeon at Tauranga Hospital, New Zealand . He graduated from the University of Melbourne and gained post-fellowship experience at the Edinburgh Breast Unit. Peter is an executive director of the Australasian Society for Breast Disease, a member of the Oncoplastic subcommittee of BreastSurgANZ and is an honorary lecturer with the University of Auckland. He is a passionate teacher in Oncoplastic surgery, having convened several Oncoplastic workshops and contributed to the University of Sydney’s Breast course. Peter performs a wide range of Oncoplastic procedures including Therapeutic Mammaplasty, Perforator flaps, fat grafting, Implant-based as well as autologous Lat Dorsi Flap reconstruction.

Dr. Javier Cortes received a degree in Medicine and Surgery from the Universidad Autónoma de Madrid in 1996. He continued his studies at the University of Navarra, specialising in Medical Oncology at the Clínica Universitaria de Navarra, where he continued as Assistant in the Department of Oncology from 2002. He was Associated Professor of Oncology in the Faculty of Medicine at the University of Navarra during that period. Dr. Cortés was awarded the title of Doctor in Medical Oncology from the University of Navarra in 2002. Since 2003, he has worked in the Department of Medical Oncology at the Hospital Vall d’ Hebron, Barcelona, where he is Coordinator of the Teaching and Training Programme for Residents in Oncology and Senior Specialist in the Area of Breast Cancer with a special interest in New Drugs Development. Dr. Cortés is Head of the Breast Cancer Unit and the Melanoma Unit.
In addition, he has two masters’ degree: “Medical Direction and Clinical Management” by the Universidad Nacional de Educación a Distancia (UNED) and “Research methodology in Health Sciences” by the Universidad Autonoma de Barcelona and a degree in “Statistics in Health Sciences” by the Universidad Autonoma de Barcelona.
Dr. Cortes is the author of more than 100 publications, especially about breast tumours and new drugs and more than 250 communications at different conferences. He actively participates in the development of numerous national and international clinical investigations, especially in relation to drugs directed against molecular targets and new chemotherapy agents, and he is an ad hoc reviewer of various oncology journals.
Dr Cortés is an active member of the Spanish, European, and American Societies of Medical Oncology (SEOM, ESMO, ASCO), a member of the Scientific Committee of the European Society of Medical Oncology and the Scientific Committee of SOLTI group.

Dr Steven David is a radiation oncologist who graduated from the University of Western Australia before completing his specialist training at the Peter MacCallum Cancer Centre in Melbourne. Subsequently, he took up a position as a sub-specialist in breast and lung cancer at the Peter MacCallum Moorabbin campus (Monash Cancer Centre). Steven has been the lead investigator in a number of local clinical trials and has been involved in recruitment to a number of international trials. His current areas of research include development and implementation of a Deep Inspiration Breath Hold Technique to reduce radiation to the heart for patients with left sided breast cancer and the use of high dose precision radiation (SABR) for the treatment of patients with metastatic disease.

Dr. Richard De Boer completed his basic medical and oncology training at the Royal Melbourne Hospital and then in 1997 undertook a 3-year breast and lung cancer clinical research fellowship at the Royal Marsden Hospital in London, working with Professor Ian Smith.
He returned to Melbourne in 2000 and since then has been a consultant medical oncologist working in both public and private practice. His primary areas of clinical interest are in breast and lung cancer, with breast cancer interests focusing on endocrine therapy and mechanisms of resistance, treatment-induced bone loss and bone metastases, and biological predictors of response/survival. He is actively involved in clinical research, and is a member of the Australian New Zealand Breast Cancer Trials Group, and head of the Breast Trials group of Cancer Trials Australia. He has authored or co-authored articles appearing in journals such as the Journal of Clinical Oncology, Annals of Oncology, The Breast and British Journal of Cancer.

Naamit Kurshan Gerber, MD is a Professor of Radiation Oncology at NYU Langone Medical Center where she serves as the Vice Chair for Education and Residency Program Director. Dr. Gerber received her AB in the history of science from Harvard College and her M.D. from the Icahn School of Medicine at Mount Sinai. She completed her residency in radiation oncology at Memorial Sloan Kettering Cancer Center. Dr. Gerber is the co-leader for the breast cancer disease management group at the Perlmutter Cancer Center at NYU. She is currently serving as the chair of the breast education committee for ASTRO and serves as a member of the NRG Breast local regional committee. She is a senior editor for Practical Radiation Oncology for breast cancer and the founding editor for the journal’s Morbidity and Mortality Column.

Dr Phillip Good is a Palliative Medicine Specialist working at Mater Health Services and St Vincent’s Private Hospital, Brisbane. He also has an appointment as a Clinical Professor at the University of Queensland, and Associate Professor at University of Technology Sydney. He tries to combine clinical practice in palliative care with research aimed at improving patient outcomes.

Kevin Kalinsky, M.D., M.S. FASCO is Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Kalinsky serves as the Director of the Division of Medical Oncology as well as the Louisa and Rand Glenn Family Chair in Breast Cancer Research.

Michael Kerin is Chair of Surgery at the University of Galway and Clinical Director of the OECI-accredited Cancer Centre for the West and North-West of Ireland. He is the incoming President of the Royal College of Surgeons in Ireland and serves as Research Director of the National Breast Cancer Research Institute (NBCRI).
He is Principal Investigator on several national and international breast cancer programmes, including Precision Oncology Ireland (POI) and the All-Island Cancer Research Institute (AICRI), and is a co-investigator on major collaborative initiatives such as the Breast Cancer Association Consortium (BCAC).
His research interests span molecular profiling, cancer risk prediction, breast cancer screening, and the development of innovative diagnostic and management approaches to breast cancer. He has secured more than €15 million in research funding, supervised 56 PhD or MD candidates, and authored or co-authored over 500 peer-reviewed publications. In 2024, he was awarded a Doctor of Science (DSc) by the National University of Ireland in recognition of his contribution to breast cancer research.

Dr Sanjeev Kumar is a Consultant Medical Oncologist at Chris O’Brien Lifehouse and Royal Prince Alfred Hospital, and a Clinician Scientist in the Biomarker Innovation Hub. He grew up in regional Australia, completed undergraduate medical studies at UNSW, and trained as a Medical Oncologist in Central Sydney and in the United Kingdom.

He embarked on a Cancer Drug Development fellowship with the University of Cambridge UK in 2015 and was subsequently awarded a University of Cambridge and Cancer Research UK scholarship in 2016 to complete a cancer molecular biology PhD at the Cancer Research UK Cambridge Institute, with a focus on Oestrogen receptor-positive breast cancer.

Sanjeev returned to Australia in 2019 to continue his clinical and academic focus on breast cancer. He has worked clinically as a medical oncologist at the Kinghorn Cancer Centre, Westmead Hospital and now solely at Chris O’Brien Lifehouse and RPA. His clinical interests include the treatment of young women with breast cancer, neoadjuvant therapy approaches and treating high risk breast cancers. He has a keen interest in the education of trainees, public engagement, biomarker research and clinical trials.

Professor Sunil Lakhani is a clinical diagnostic and molecular pathologist. He is Senior Staff Specialist, Pathology Queensland and Sullivan Nicolaides Pathology and Group Leader, University of Queensland Centre for Clinical Research, Brisbane, Australia. His research interests include lobular carcinoma, triple negative and metaplastic breast cancer and therapeutic development of brain metastases.
He was Editor, WHO 4th and 5th Ed Tumours of the Breast (2012, 2019). He is recipient of the Distinguished Pathologist Medal, Australasian Division of IAP, Distinguished Fellow Award, The Royal College of Pathologists of Australasia. In 2017, he was elected Fellow of the Australian Academy of Health and Medical Sciences and in 2025, received the AMAQ award for Excellence in Health Care.

Prof Elgene Lim is a medical oncologist at The Kinghorn Cancer Centre, St Vincent’s Hospital, and leads the Connie Johnson Breast Cancer Research Group at the Garvan Institute of Medical Research. He obtained his training at the University of Melbourne, Walter& Eliza Hall of Medical Research, and Dana-Farber Cancer Institute. He is the inaugural National Breast Cancer Foundation Endowed Chair and the Principal Cancer Theme lead at the UNSW medical school. His research team performs clinically focused laboratory research, utilizing patient-derived breast tumour xenografts for the evaluation of novel therapies. A major focus of his group is on overcoming resistance to currently used endocrine therapies.

Prof. Bruce Mann is Professor of Surgery at the University of Melbourne and Director of The Breast Service at the Royal Melbourne and Royal Women’s Hospital in Melbourne. He is on the council of Breast SurgANZ, the Scientific Advisory Committee of the ANZ Breast Cancer Trials Group and is past president of the Clinical Oncology Society of Australia. He has been involved in many clinical trials and much clinical and translational research regarding breast cancer, with his main research interest being tailoring treatment to the disease and the patient.

Nicole McCarthy
Associate Professor Nicole McCarthy MBBS (Hons), MHSc, FRACP is a Consultant Medical Oncologist at Icon Cancer Care at the Wesley Medical Centre and Wesley Hospital in Brisbane and her academic appointment is with the School of Medicine, University of Queensland . She completed a 3 year Medical oncology fellowship at the National Cancer Institute, Bethesda MD and a Masters in Health Sciences in Clinical Trial Design through Duke University. She is an academic clinician and her clinical practice and translational research focuses on the multifaceted aspects of breast cancer care and management. She led the Breast Cancer Clinical trials unit at the Royal Brisbane and Women’s Hospital for over 10 years and now provides leadership for the breast cancer clinical trials component of ICON Research Foundation Clinical Trials Unit, the largest national private oncology provider. A/Prof McCarthy is considered an opinion leader in breast cancer management at a local and national level and her own investigator-initiated clinical trials have been incorporating new agents into neoadjuvant breast cancer treatment. A/Prof McCarthy has been the Chair of the Systemic Therapy Subcommittee of the ANZ Breast Cancer Trials Group Scientific Advisory Committee (SAC) since 2007 and a member of the SAC since 2004. She has been the Australian Principal Investigator on several international clinical trials. A/Prof McCarthy has been a member of a number of national breast cancer guideline panels and has played a close role with breast cancer consumer advocacy groups.

Stuart McIntosh
Professor of Surgical Oncology at Queen’s University in Belfast, and a consultant oncoplastic breast surgeon at Belfast City Hospital.

Stuart is an experienced clinical trialist, with a particular interest in neoadjuvant, peri-surgical and treatment de-escalation studies, and is Chief Investigator for the UK SMALL trial, as well as holding surgical leadership roles in several other trials. He is also one of the Royal College of Surgeons Surgical Specialty Leads for Breast Surgery, responsible for supporting the development and delivery of breast cancer surgical trials nationally. Additionally, he chairs the Northern Ireland Cancer Trials Network, responsible for the delivery of cancer trials across the five cancer hospitals in Northern Ireland. Stuart’s laboratory research interests include the DNA damage driven immune response in breast cancer.

Elizabeth Morris M.D. is Professor and Chair of Radiology at the University of California, Davis (UCD) School of Medicine. Dr. Morris graduated summa cum laude from UCD in Biochemistry and received her medical degree from the University of California, San Francisco (UCSF). She completed her residency at Weill Cornell Medical College (WCMC) and a body/breast imaging fellowship at Memorial Sloan Kettering Cancer Center (MSKCC) where she remained on faculty until December 2020 where she was the Chief of the Breast Imaging Service and Larry Norton Endowed Chair.
Dr. Morris is a fellow of the American College of Radiology (ACR), Society of Breast Imaging (SBI) and International Society of MR in Medicine (ISMRM) and is past president of the SBI. She was awarded the SBI gold medal in 2024. She was the inaugural Equity Diversity & Inclusion officer of the ISMRM and co-chair of the Women of ISMRM (WISMRM). She is on the board of the Society of Chairs in Academic Radiology (SCARD) and currently serves as the Chair of the Council of Chairs at UCD.
Her research focus is on how best to use newer techniques such as MRI for early breast cancer detection and to improve the workup of breast lesions. In collaboration with her colleagues, she has written over 230 papers, 40 chapters, and 5 books about breast disease with an emphasis on the use of MRI. She has lectures widely both nationally and internationally at over 320 conferences. She has mentored over 50 international research fellows. She has grants from NCI, RSNA, Komen Foundation, and Breast Cancer Research Foundation. She has authored a book “Breast MRI: Diagnosis & Intervention”. Her recent research efforts have involved looking at imaging biomarkers to assess risk and treatment response.

Samantha Moules has been working as a cancer nurse for over 25 years, both in Australia and internationally. She holds a Master’s degree in Oncology Nursing, a Graduate Certificate in Breast Cancer, and is an accredited clinical supervisor.
For the past 10 years, Samantha has worked as a McGrath Breast Care Nurse dedicated to supporting patients with early and advanced breast cancer. She currently works at Genesis Care St Leonards and Frenchs Forest, and also serves as a Nurse Clinical Lead with the McGrath Foundation, supporting McGrath Cancer Care Nurses across New South Wales / ACT.
Samantha has a special interest in exploring the unmet supportive care needs of patients across different stages of their, as well as the care impact of multidisciplinary care. She is planning to complete her Nurse Practitioner qualification in 2026, with a focus on addressing unmet needs, reducing symptom burden, and improving long-term outcomes for people living with and beyond cancer.

Associate Professor Carolyn Nickson is an epidemiologist specialising in the evaluation of cancer screening, diagnosis and treatment, through epidemiological studies, clinical and cost-effectiveness modelling, policy analysis and implementation studies. She heads a research team at the Cancer Elimination Collaboration in the Sydney School of Public Health, also holding appointments at the University of Melbourne and Melbourne Health. In addition to an academic research program she has led numerous government-funded evaluations including the ‘Breast ROSA’ project on behalf of Cancer Council Australia, which explored options for more risk-based approaches to breast cancer screening in the Australian setting.

Kerry Patford is the Chief Nurse at McGrath Foundation, a role that she has held in some capacity since 2019, having joined the McGrath Foundation in 2009. Kerry has been heavily involved in the development of the McGrath Models of Care, with an emphasis on supporting cancer nurses to provide optimal, evidence based to care to people with cancer, regardless of where they live or the type of cancer they have.

Nirmala Pathmanathan
Nirmala Pathmanathan is a specialist breast pathologist. She is the Service Director of the Westmead Breast Cancer Institute in Sydney (a multidisciplinary breast diagnostic and treatment centre servicing Western Sydney), a specialist breast pathologist with Douglass Hanly Moir Pathology in Sydney and the Director for BreastScreen Program for Sydney West. She is a Clinical Associate Professor with the University of Sydney, Faculty of Medicine and Health. Her other roles have included National Clinical Advisory Board Member for BreastScreen Australia, Advisory group member for Cancer Australia guidelines, Chair of the pathologist quality group for BreastScreen NSW and Executive Committee membership for the Australian Breast Cancer Tumour Bank. Her research interests include prognostic markers in ER positive breast cancer and triple negative breast cancer.

Kirsten Pilatti
Chief Executive Officer

Kirsten has spent two decades in the not-for-profit space in Australia, cultivating a deep understanding of the cancer sector through her roles at BCNA and at Cancer Council Victoria. She is highly regarded in the industry and has a visible media profile thanks to her passion and commitment to giving everyone affected by breast cancer a voice and reducing the disparity of care across the country.
In 2024, Kirsten was appointed as a member of the newly formed Health Technology Assessment (HTA) Review Implementation Advisory Group (IAG), which is geared towards achieving generational reform in Australia’s healthcare system.
She leads a team who is focused on better advocacy and support for those affected. She is proud of how BCNA has shone a spotlight on important issues such as the those faced by people living with metastatic breast cancer, access to breast reconstruction, driving changes to the healthcare system, and achieving equity of access to ensure all Australians can access the very best care, treatment and support.

Dr Janine Porter-Steele OAM, RN, MN, PhD is a Senior Research Fellow at Flinders University and a clinical nurse at The Wesley Hospital Choices Cancer Support Centre in Brisbane. With a career spanning the UK and Australia, she has worked across nursing, midwifery, women’s health, and oncology, including managing the Choices Cancer Support Centre.
Janine leads and supports multiple lifestyle-focused cancer survivorship studies, contributing significant expertise in clinical governance and the development of the Women’s Wellness suite of programs. She has delivered these programs in various formats to diverse groups of women across the cancer continuum. Her PhD focused on Sexual health and wellbeing for women after a cancer diagnosis and treatment.
She holds a Certificate IV in Training and Assessment and adjunct research appointments with Wesley Medical Research Institute, Griffith University and the University of Queensland. In 2024, she was awarded the Medal of the Order of Australia (OAM) for her services to nursing.

Shelley Potter PhD FHEA FRCS
Shelley Potter is Professor of Surgical Oncology at Bristol Medical School and Consultant Oncoplastic Breast Surgeon at North Bristol NHS Trust.
Her research interests focus on improving outcomes for women with breast cancer through the development and delivery of high-quality patient-centred research. She is an experienced researcher who had led several national and international collaborative oncoplastic and reconstructive breast surgical projects including the iBRA and TEAM studies and is currently Chief Investigator for Brighter, ANTHEM and Pre-BRA. Recent work has focused on optimisation of breast cancer treatment.
Her leadership national roles include Royal College of Surgeons of England Surgical Specialty Lead for Breast Surgery, Chair of iBRA-NET and Secretary to the British Breast Group.

Mackenzie Rhodes is a proud Bundjalung woman from the Northern Rivers of NSW, working as a Senior Aboriginal Research Assistant for the First Nations Cancer and Wellbeing Research Program, within the University of Queensland’s School of Public Health. She has a background in Social Work with experience working with Aboriginal and Torres Strait Islander people, young people, the out of home care sector, the mental health sector and qualitative research practices.

Dr. Alistair Ring is a Consultant Medical Oncologist at The Royal Marsden. He undertook his pre-clinical training at the University of Cambridge and clinical training at the University of Oxford, qualifying in 1997. His oncology training was based at The Royal Marsden, St George’s and Guy’s Hospitals, London. He gained his MD research degree in 2005 from the Institute of Cancer Research (ICR) at the University of London.
In 2008 he was appointed as Senior Lecturer in Oncology at Brighton and Sussex Medical School, where he held various roles including Director of the Brighton NIHR Clinical Research Facility. In 2014 he was appointed Consultant Medical Oncologist at The Royal Marsden.
He has specialist interests in the management of metastatic and early breast cancer and the management of cancer in older patients. He has a major interest in research, and is UK lead for a number of research studies examining the roles of aspirin and modern targeted drugs in the management of breast cancer. He is Chair of the Committee for Clinical Research at The Royal Marsden and the ICR. Dr Ring has published widely in peer-reviewed journals and in 2015, edited the textbook Problem Solving in Older Cancer Patients and in 2017 Breast Cancer Survivorship.
In 2018 Dr Ring was appointed Honorary Reader in Breast Cancer Clinical Trials, at the Institute of Cancer Research.

Dr Allison Rose MB. BS, M. MED, FRANZCR
Director, Northwestern BreastScreen
Head, The Royal Melbourne & The Women’s Hospital Breast Imaging Service Consultant Radiologist, The Royal Melbourne Hospital Associate, University of Melbourne Radiology Department.Dr Allison Rose worked at the Victorian Pilot Program for the Early Detection of Breast Cancer from 1989 under the auspice of The Royal Melbourne Hospital and became Director in 1999. In 2009 she became Head of Breast Imaging for the combined Royal Melbourne & The Women’s Hospital Breast Service & in this role she has led the team to deliver fully integrated comprehensive breast imaging across diagnostic and screening sites. She was instrumental in establishing Breast MRI & MRI guided biopsy for the service and more recently developed protocols for contrast enhanced digital mammography. Her current interests are focussed on risk based tailored breast screening and appropriate staging of diagnosed breast cancer- BreastStage.

A/Prof Ben Smith
Daffodil Centre, University of Sydney and Cancer Council NSW

A/Prof Ben Smith is a Cancer Institute NSW Career Development Fellow and Senior Implementation Scientist, at the Daffodil Centre, University of Sydney and Cancer Council NSW. Ben is leading the development and implementation of a step-by-step plan (i.e., clinical pathway) for health professionals to identify and provide tailored support to people experiencing fear of cancer recurrence

Lesley Stafford BA(Hons) MA(Psych) MPsych(Clin) PhD is a clinical psychologist and academic psycho-oncologist with extensive clinical and research experience in breast cancer. She has authored 85 publications and is a member of the Scientific Advisory Committee of Breast Cancer Trials. She is an Associate Professor in the Department of Surgery at Melbourne University and works in private practice.

Professor Alastair Thompson trained and practiced as a clinician-scientist focused on multidisciplinary patient care alongside translational “bench to bedside” studies and innovative clinical trials in cancer. He initiated and led a successful breast cancer laboratory program and provided leadership for a cancer center in Dundee, United Kingdom (UK). He chaired the UK national breast cancer trials portfolio of 120 studies led the national breast cancer tissue bank and engaged in a range of pivotal roles in key drug, radiation therapy and surgical trials involving the UK, Europe, the United States and Australia. Since moving to the US in 2014, he has focused on improving treatment for breast cancer patients with innovative surgical techniques and clinical trials.
Thompson is an active member of SSO, ASBrS, ASCO and AACR. With successful peer reviewed funding from US government and international charitable sources spanning laboratory to clinical studies, successful supervision of 24 postgraduate students to date and over 400 publications in the highest impact factor clinical and scientific journals. His key mission remains improving care for those with cancer.

Dr Melanie Walker MBBS FRACS is a specialist breast surgeon based in Melbourne, practising in both public and private settings. She is Clinical Lead of Breast Surgery at Alfred Health and Clinical Lead of the Australian Breast Device Registry at Monash University. Dr Walker served as President of Breast Surgeons of Australia & New Zealand from 2020 to 2025 and has held multiple leadership roles in surgical governance, audit and education.
Her clinical practice encompasses breast cancer surgery and oncoplastic techniques, with a strong focus on quality improvement and data-driven outcomes research. She is actively involved in national registry science, multidisciplinary collaboration and surgical training.

Leilani Way is a Cancer Survivorship Clinical Nurse Consultant and Operational Lead of the Mater Statewide Cancer Survivorship Service across Queensland and Northern New South Wales, leading the development and implementation of scalable models of survivorship care. She is undertaking a Higher Degree Research in implementation science, focused on translating supportive care evidence into sustainable practice to improve outcomes for people living with and beyond breast cancer.

Dr Belinda Yeo (FRACP, MD, MBBS, BA)

Belinda Yeo is a Medical Oncologist specialising in breast cancer and the Deputy Director of Medical Oncology at Austin Health in Melbourne. She is also a Clinician Scientist at the Olivia Newton-John Cancer Research Institute.
After training in Sydney, she joined the Breast Unit at The Royal Marsden Hospital in London as a Clinical and Research Fellow. She completed a Master’s Degree at The University of London and The Institute of Cancer Research in novel genomic and non-molecular breast cancer risk assays.
Belinda was co-lead of the VCCC Research and Education Stream for Breast Cancer until 2023. She actively supervises PhD students, serves as a clinical trial investigator, and continues her translational research at the ONJ Centre, focusing on improving personalised care and minimising treatment toxicities for patients with breast cancer.

Dr Leona Yip is a Melbourne-trained dermatologist with subspecialty expertise and a PhD in the field of alopecias. Dr Yip is based in Brisbane, where she is Director of Skin Partners. She has also previously worked extensively in both private and public practice in Melbourne and Canberra.
Dr Yip’s PhD thesis on female pattern hair loss was nominated for the Chancellor’s Prize, and her research work won multiple awards and research grants. She is well-published in various aspects of dermatology and is a Reviewer for multiple peer-reviewed medical journals. Dr Yip served as an Editorial Consultant for The British Journal of Dermatology from 2018-2021.
Dr Yip is a member of multiple international and Australian expert groups; and she has also served as Medical Consultant, Key Opinion Leader and Advisory Board Member for various leading pharmaceutical and dermocosmetic companies. She is passionate about skin health advocacy and education to improve skin health literacy. She regularly speaks at medical meetings and commonly features in media as a skin and hair health expert. Dr Yip is currently Head Dermatologist for Cricket Australia.
Her broad range of unique expertise that incorporates her specialist training, research and academic background, years of real-world clinical experience, dermatology expert group memberships and her robust relationship with industry leaders as well as mainstream media enable her to offer an all-rounded and holistic perspective to all facets of dermatology.